• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Medicus Sciences Acquisition Corp.

    2/14/22 4:22:36 PM ET
    $MSAC
    Blank Checks
    Finance
    Get the next $MSAC alert in real time by email
    SC 13G 1 t50555075a.htm SCHEDULE 13G
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. __)*

    Medicus Sciences Acquisition Corp.
    (Name of Issuer)
    Class A ordinary shares, $0.0001 par value
    (Title of Class of Securities)
    G5960S108
    (CUSIP Number)

    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. G5960S108
    13G
    Page 2 of  8 Pages
     
    1
    NAME OF REPORTING PERSON
    Third Point LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐
    (b)  ☐
    3
    SEC USE ONLY


    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    790,000
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    790,000
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    790,000
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
    N/A
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    8.5%
    12
    TYPE OF REPORTING PERSON
    OO


    CUSIP No. G5960S108
    13G
    Page 3 of  8 Pages
     
    1
    NAME OF REPORTING PERSON
    Daniel S. Loeb
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐
    (b)  ☐
    3
    SEC USE ONLY


    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
    0
    6
    SHARED VOTING POWER
    790,000
    7
    SOLE DISPOSITIVE POWER
    0
    8
    SHARED DISPOSITIVE POWER
    790,000
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    790,000
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
    N/A
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    8.5%
    12
    TYPE OF REPORTING PERSON
    IN

    Item 1(a): Name of Issuer:
    Medicus Sciences Acquisition Corp. (the "Issuer").
    Item 1(b): Address of Issuer's Principal Executive Offices:
    The Issuer's principal executive offices are located at 152 West 57th Street, Floor 20, New York, New York 10019.

    Item 2(a): Name of Person Filing:
     
    (i)
    Third Point LLC, a Delaware limited liability company (the “Management Company”), which serves as investment manager or adviser to a variety of hedge funds and managed accounts (all such funds and accounts, collectively, the “Funds”), with respect to the Class A Ordinary Shares (as defined in Item 2(d)) directly owned by the Funds; and
     
    (ii)
    Mr. Daniel S. Loeb (“Mr. Loeb”), who is the Chief Executive Officer of the Management Company and controls its business activities, with respect to the Class A Ordinary Shares indirectly beneficially owned by Mr. Loeb by virtue of such position.

       
    The Management Company and Mr. Loeb are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

    Item 2(b): Address of Principal Business Office or, if None, Residence:
    The address of the principal business office of the Management Company and Mr. Loeb is 55 Hudson Yards, New York, New York 10001.
    Item 2(c): Citizenship:
    The Management Company is organized as a limited liability company under the laws of the State of Delaware. Mr. Loeb is a United States citizen.
    Item 2(d): Title of Class of Securities:
    Class A ordinary shares, $0.0001 par value ("Class A Ordinary Shares").
    Item 2(e): CUSIP Number:
    G5960S108.

    Item 3:
    If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
     

     
    A.
    [ ]
    Broker or dealer registered under Section 15 of the Act,
     
    B.
    [ ]
    Bank as defined in Section 3(a)(6) of the Act,
     
    C.
    [ ]
    Insurance Company as defined in Section 3(a)(19) of the Act,
     
    D.
    [ ]
    Investment Company registered under Section 8 of the Investment Company Act of 1940,
     
    E.
    [ ]
    Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E),
     
    F.
    [ ]
    Employee Benefit Plan or Endowment Fund in accordance with 13d-1 (b)(1)(ii)(F),
     
    G.
    [ ]
    Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G),
     
    H.
    [ ]
    Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act,
     
    I.
    [ ]
    Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940,
     
    J.
    [ ]
    Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

    Item 4: Ownership:

    A. Third Point LLC
    (a) Amount beneficially owned: 790,000 Class A Ordinary Shares.
    (b) Percent of class: 8.5%. The percentages used herein and in the rest of this Schedule 13G are calculated based upon the 9,292,000 Class A Ordinary Shares issued and outstanding as of November 4, 2021, as reported in the Issuer’s Amendment No. 1 to its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on January 20, 2022. Except as described in the preceding sentence, all amounts reported in this Schedule 13G are as of the opening of the market on February 14, 2022.
    (c) Number of shares as to which such person has:
    (i)
    Sole power to vote or direct the vote: -0-
    (ii)
    Shared power to vote or direct the vote: 790,000
    (iii)
    Sole power to dispose or direct the disposition: -0-
    (iv)
    Shared power to dispose or direct the disposition: 790,000

    B. Daniel S. Loeb
    (a) Amount beneficially owned: 790,000 Class A Ordinary Shares.
    (b) Percent of class: 8.5%. The percentages used herein and in the rest of this Schedule 13G are calculated based upon the 9,292,000 Class A Ordinary Shares issued and outstanding as of November 4, 2021, as reported in the Issuer’s Amendment No. 1 to its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on January 20, 2022. Except as described in the preceding sentence, all amounts reported in this Schedule 13G are as of the opening of the market on February 14, 2022.

    (c) Number of shares as to which such person has:
    (i)
    Sole power to vote or direct the vote: -0-
    (ii)
    Shared power to vote or direct the vote: 790,000
    (iii)
    Sole power to dispose or direct the disposition: -0-
    (iv)
    Shared power to dispose or direct the disposition: 790,000

    Item 5: Ownership of Five Percent or Less of a Class:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: ☐
    Item 6: Ownership of More than Five Percent on Behalf of Another Person:
    Other than as set forth herein, no other person has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the securities reported herein.
    Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
    Not applicable.
    Item 8: Identification and Classification of Members of the Group:
    Not applicable.
    Item 9: Notice of Dissolution of Group:
    Not applicable.
    Item 10: Certification:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    [Signatures on following page]

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Dated: February 14, 2022
     
    THIRD POINT LLC
         
     
    By: Daniel S. Loeb, Chief Executive Officer
         
     
    By:
    /s/ William Song
       
    Name: William Song
       
    Title: Attorney-in-Fact
     
         
     
    DANIEL S. LOEB
         
     
    By:
    /s/ William Song
       
    Name: William Song
       
    Title: Attorney-in-Fact
         
         

    EXHIBIT INDEX

    Exhibit 99.1:
    Joint Filing Agreement, dated February 14, 2022, by and between Third Point LLC and Daniel S. Loeb.
    Exhibit 99.2:
    Power of Attorney granted by Daniel S. Loeb in favor of William Song and Joshua L. Targoff, dated February 17, 2021, was previously filed with the SEC on March 4, 2021 as Exhibit 24 to the Form 4 filed by Third Point LLC and Daniel S. Loeb with respect to Radius Global Infrastructure Inc. and is incorporated herein by reference.

    Get the next $MSAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MSAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MSAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medicus Sciences Acquisition Corp. Announces Liquidation

    NEW YORK,  Feb. 13, 2023 /PRNewswire/ -- Medicus Sciences Acquisition Corp. (the "Company") (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Charter"), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $10.18. As of the close of business on Februar

    2/13/23 4:00:00 AM ET
    $MSAC
    Blank Checks
    Finance

    $MSAC
    SEC Filings

    View All

    SEC Form 15-12G filed by Medicus Sciences Acquisition Corp.

    15-12G - Medicus Sciences Acquisition Corp. (0001836517) (Filer)

    2/27/23 2:48:15 PM ET
    $MSAC
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Medicus Sciences Acquisition Corp.

    25-NSE - Medicus Sciences Acquisition Corp. (0001836517) (Subject)

    2/17/23 4:06:19 PM ET
    $MSAC
    Blank Checks
    Finance

    Medicus Sciences Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)

    2/13/23 6:11:23 AM ET
    $MSAC
    Blank Checks
    Finance

    $MSAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)

    SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)

    2/12/24 6:11:11 PM ET
    $MSAC
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)

    SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)

    2/8/24 2:19:35 PM ET
    $MSAC
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)

    SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)

    2/14/23 4:33:34 PM ET
    $MSAC
    Blank Checks
    Finance